Pulse Canada   Report issue

Academic/Hospital Phase 2
Founded: Winnipeg Canada (1997)

Organization Overview

First Clinical Trial
2007
NCT00839774
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Pulse Canada

Active Ingredients

Drugs in Phase 2 Trials (2)

bean (1 trial)

pea (5 trials)

Drugs in Other Trials (7)

almond (1 trial)

chickpea (1 trial)

corn (1 trial)

lentil (1 trial)

oryza sativa (1 trial)

pinto bean (1 trial)

soybean (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 9